Global Transcatheter Tricuspid Valve Intervention (TTVI) Market–Insights and Forecast (2021-2030)

DELHI, India - Nov. 15, 2021 - PRLog -- he Global Transcatheter Tricuspid Valve Intervention (TTVI) market is projected to display noteworthy growth and estimated to reach value of USD 10.17 billion by the year 2030 with Europe region leading the regional market share. Demand for transcatheter valvular therapeutics for tricuspid valve diseases in line with rising aged population globally that are more prone to such diseases is likely to boost the market growth. Moreover, tricuspid valve intervention (repair and replacement) device developments and their upcoming medical approvals across countries is also creating positive outlook for the market growth.

European region is estimated to be the fastest growing regional market for the TTVI in the forecast period of 2021-25, whereas Asia-Pacific will take the lead in the second half from 2026-30. The growth of the European market can be attributed to early approvals of some tricuspid valve repair devices, rising burden of tricuspid valve disorders, ageing population and high per-capita healthcare spending in regional countries.

The emergence of COVID-19 has brought the world to a standstill. This health crisis has brought an unprecedented impact on businesses across industries, including the cardiovascular (heart) care and other related industries.

Scope of the Report

• The report analyses the Transcatheter Tricuspid Valve Intervention Market by value (USD Millions).
• The report analyses the Transcatheter Tricuspid Valve Intervention Market by Intervention Type (Tricuspid Valve Repair (TVr) and Tricuspid Valve Replacement (TVR)).
• The report analyses the Transcatheter Tricuspid Valve Intervention Market by Disease Type (Tricuspid Regurgitation (TR) and Tricuspid Stenosis (TS))
• The Global Transcatheter Tricuspid Valve Intervention Market has been analysed By Region (North America, Europe, Asia Pacific, and LAMEA).
• The Global Transcatheter Tricuspid Valve Intervention Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, China, Japan, India, and Australia).
• The report tracks competitive developments, strategies, mergers and acquisitions and new product developments. The companies analysed in the report include Edwards Lifesciences, Abbott, Medtronic PLC, LivaNova PLC, CryoLife, Venus MedTech, NaviGate Cardiac Structures, Jenscare Biotech., Huihe Medical, and 4Tech Cardio Ltd.

For more Information:

https://azothanalytics.com/report/healthcare-and-pharmaceutical/global-transcatheter-tricuspid-valve-intervention-ttvi-market-analysis-by-intervention-type-tvr-tvr-disease-type-tr-ts-end-user-by-region-by-country-2021-edition-market-insights-pipeline-covid-19-implications-competition-and-forecast-2021-2030

Vishal Sharma

(Business Development Manager)

Address:  CS - 55, Third Floor, Ansal Plaza,

Vaishali, Ghaziabad

U.P., India

Mobile: +91-9873426288

Tel: +91-120- 4298235

Mail ID - info@azothanalytics.com